adverse effects of glp 1 Managing Side GLP-1 Receptor Agonists – Transformation Weight Control GLP-1 Gut Side Effects: Bloating
Description
2021 NEJM) and 20.9% in SURMOUNT-1 (Jastreboff et al
Brown J, Martis R, Hughes B, Rowan J, Crowther CA
However, significant fluctuations, if not well-controlled, can lead to diabetic retinopathy
Tirzepatide demonstrated remarkable weight-reducing efficacy in randomized controlled trials such as SURMOUNT-1 and SURMOUNT-2, with mean body-weight reductions ranging from 15 to 22.5% (32, 33)
[DOI] [PMC free article] [PubMed] [Google Scholar] 23.F.F
Compounded semaglutide and tirzepatide products are not the same as FDA-approved brand-name medications
